Outpatient PPS Comments Critical Of HCFA APC Payment Proposals
This article was originally published in The Gray Sheet
Executive Summary
Proposed Medicare reimbursement for brachytherapy seed implants for prostate cancer treatment under the Health Care Financing Administration's proposed outpatient prospective payment system (PPS) is vastly inadequate and fails to account for benefits the therapy confers on patients, David Sherman, MD, St. Joseph's Hospital, Milwaukee contends.